Increased globalization and the growing complexities around innovative, next-generation therapies has forced biopharmaceutical leaders to reexamine their clinical supply chain ...

In the age of precision and personalized medicine, life science companies can develop treatments designed to target almost any patient’s ...

The promising outlook for liquid biopsy diagnosis has sparked the interest of many in the biotech industry. The speed, ease, ...

Clinical trial design, like much of the industry, is experiencing a wave of innovation and disruption. Classical randomized control trials ...

A paper published this month proving that the use of RNA transposons can improve the CRISPR process has excited the ...

Clinical trials have long been viewed as complicated and high-volume endeavors, involving the widespread recruitment of patients, supply chain planning ...

The most innovative organizations have demonstrated their success stems from creative strategy paired with iterative and efficient execution. It’s all ...

Underlying all of the widespread uses of genetic testing—diagnostic testing, carrier testing, prenatal testing, consumer-oriented genetic testing, etc.—few issues loom ...

“The right dose of the right medicine delivered to the right patient at the right time…and at the right cost”.  ...

Over the last two years, discussions about the applications of AI have broken through the mainstream and reached a level ...

The meticulous art of R&D demands extensive collaboration, mastery of technical skills, and scientific acumen. In and of itself, the ...

For pharmaceutical and biotechnology companies focusing on research and development, prioritizing data transparency and clinical study reporting (CSR) is a ...